Skip to main content

Table 4 Effect of biomarker level differences from day 5 to day 30 on cardiovascular events, by per protocol population

From: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia

  CV Events
OR (95% CI)a p value
ProADM Difference 1.43 (0.11, 18.56) 0.79
PCR Difference 1 (0.97, 1.02) 0.80
PCT Difference 0.09 (0.0003, 30.82) 0.42
  1. OR odds ratio, IC confidence interval, CV cardiovascular
  2. aOR is adjusted for the Charlson comorbidity index and the biomarker level on the 5th day